Sales & Marketing

The new office officially opened on September 8, and will enhance the firm's ability to serve clients in Boston and the surrounding area.

Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences—where the common thread seems clear: the messenger matters.

A fresh look at how industry benchmarks can help fortify new drug launches to overcome today’s new market-entry barriers and higher expectations.

Launch of novel drug for rare neuromuscular disorder seeks to give voice to the patients.

Use against pair of pathways could pave way for standout in stocked eye disease market.

Tapping the potential of new market mindset in insomnia—delivering a quality next day.

Dual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.

More favorable administration, reimbursement could separate latest PCSK9 entrant.

What the rising rate of physician-hospital affiliations means for pharma.

Latest innovation solves pharma brands' and agencies' long-standing need for transparent, data-driven DTC audience creation and campaign planning.

The fast-growing global naming and branding firm hired Switzerland-based Dan Hunt as managing director, Europe.

Pharm Exec chats with Bridget Seay of epocrates about the non-personal promotion landscape as face-to-face contact with physicians dwindles.

Ryan Olohan, formerly Google Healthcare Managing Director, joins celebrated global health commercialization partner as Executive Vice President, Growth.

The multi-regional agreement aims to commercialize Odevixibat in Canada and Israel, for the treatment of patients with cholestatic liver diseases.

Capsulomics announces leadership appointment of industry veterans Stacey Gilbert and Lisa Kann.

Award adds to industry accolades received by the March of Dimes marketing department recognizing outstanding work in creative video, integrated campaigns, and more.

Sam Ingram and Hui Tang reinforce the agency's commitment to digital experience and data & analytics.

The two technologies are helping HCPs spread information and collect data in new ways.

All business units will incorporate CSL name and branding to signify one company.

First party validated NPI targeting, clinical data and measurement sets PulsePoint apart from other CTV platforms.

Tilton will bring together Ruder Finn's extensive social and digital capabilities under the healthcare banner and be responsible for the strategic development and execution of digital programs for clients across product, policy, and corporate healthcare communications.

Expert naming process valued in fast-tracked approval as drug clears FDA regulatory hurdles.

Multi-year initiative will leverage NFL Alumni events and educational opportunities to raise awareness about effective opioid alternatives.

In a newly-created role, Theo Ahadome will be responsible for driving the next phase of the company’s global growth.

Mindy will be the creative voice of the agency, responsible for providing Greater Than One clients with strategic creative direction and oversight from inception through execution.

Proximyl Health’s Halen Dang, VP, Creative Director of Art and Carrie Morris, VP, Creative Director of Copy discuss remote teamwork and how to successfully lead agency creative teams with hybrid schedules.

National healthcare consultancy and marketing firm hires Senior Vice President of Business Development to meet growing market demand and client partnership opportunities.

Seasoned executive brings expertise with high-growth companies as pharma programmatic advertising spending dramatically increases.

Study underscores broadcast radio’s advertising value for pharmaceutical brands.

An experienced science and business leader, Dr. Fiorotti assumed responsibilities on August 1, 2022 and will oversee all aspects of Immunologix Laboratories commercial function, including business development, marketing, and commercial growth.